Document ID: chunk:federal_register_of_legislation:F2016L00557:reg:9:p3
Version: federal_register_of_legislation:F2016L00557
Segment Type: reg
Provision Reference: reg 9 (pt 3/4)
Character Range: 8669–11639

class of drugs from the specified list of drugs, for a continuous period of at least three months  before the clinical worsening of cholelithiasis, and where treatment has ceased, the clinical worsening of cholelithiasis has occurred within three months of cessation;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(29)      having cirrhosis of the liver at the time of the clinical worsening of cholelithiasis;
(30)      having non-alcoholic fatty liver disease at the time of the clinical worsening of cholelithiasis;
Note: non-alcoholic fatty liver disease is defined in the Schedule 1 - Dictionary.
(31)      for males only, having hepatitis C virus infection at the time of the clinical worsening of cholelithiasis;
(32)      having a haemolytic disease at the time of the clinical worsening of cholelithiasis;
Note: haemolytic disease is defined in the Schedule 1 - Dictionary.
(33)      having Crohn's disease at the time of the clinical worsening of cholelithiasis;
Note: Crohn's disease is defined in the Schedule 1 - Dictionary.
(34)      having an ileal resection or ileal bypass before the clinical worsening of cholelithiasis;
(35)      having type 2 diabetes mellitus at the time of the clinical worsening of cholelithiasis;
Note: type 2 diabetes mellitus is defined in the Schedule 1 - Dictionary.
(36)      having total parenteral nutrition for a continuous period of at least three weeks before the clinical worsening of cholelithiasis, and where total parenteral nutrition has ceased, the clinical worsening of cholelithiasis has occurred within 30 days of cessation;
Note: total parenteral nutrition is defined in the Schedule 1 - Dictionary.
(37)      being pregnant within the six months before the clinical worsening of cholelithiasis;
(38)      having estrogen therapy for a continuous period of at least three months before the clinical worsening of cholelithiasis, and where estrogen therapy has ceased, the clinical worsening of cholelithiasis has occurred within six months of cessation;
Note: estrogen therapy is defined in the Schedule 1 - Dictionary.
(39)      having a spinal cord injury at the time of the clinical worsening of cholelithiasis;
Note: spinal cord injury is defined in the Schedule 1 - Dictionary.
(40)      having a gastric or oesophageal resection, or another operation that included a vagotomy, before the clinical worsening of cholelithiasis;
(41)      having a foreign body in the biliary tract, or a mechanical obstruction of the biliary tract, before the clinical worsening of cholelithiasis;
Note: foreign body and mechanical obstruction of the biliary tract are defined in the Schedule 1 - Dictionary.
(42)      having a parasitic disease from the specified list of parasitic diseases of the biliary tract, at the time of the clinical worsening of cholelithiasis;
Note: specified list of parasitic diseases is defined in the Schedule 1 - Dictionary.
(43)      having bacterial infection of